Mobile Education and Telephone Monitoring for ICD Patients: Effects on Anxiety, Acceptance, and Self-Efficacy
Launched by AKDENIZ UNIVERSITY · Apr 11, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
1. Definition and Importance of the Problem
Implantable cardioverter defibrillators (ICDs) are devices developed to prevent sudden cardiac death resulting from ventricular arrhythmias. According to the 2017 guidelines of the European Heart Rhythm Association, the annual number of ICD implantations per million people is reported to be 107 worldwide and 115 in Turkey. Furthermore, over the past decade, implantation rates have increased by 44% globally and 804.1% in Turkey. Although ICD therapy has been proven to reduce mortality by 28-40% and is more effective than antiarrhythmic drugs, l...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having an ICD implant
- • Being able to read and write
- • Being 18 years of age or older
- • Not having a cognitive or communication disability
- • Not having a diagnosed psychiatric disease
- • Not having a generalized anxiety disorder (GAD-7 test score \<8)\*
- • Not having a vision problem to the extent that it prevents the use of technological devices
- • Having the knowledge and skills to use technological devices
- • Having a smartphone that runs on the Android operating system and has internet access
- • Agreeing to participate in the study
- Exclusion Criteria:
- • Patient not continuing after the second telephone follow-up phase of the study
- • Not using the mobile application regularly (frequency of use monitored by the application)
About Akdeniz University
Akdeniz University is a leading academic institution located in Antalya, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Akdeniz University leverages its extensive expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a diverse range of stakeholders, including healthcare professionals, researchers, and industry partners, to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Through its dedication to excellence in research, Akdeniz University plays a pivotal role in contributing to the development of new therapies and enhancing the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Antalya, , Turkey
Antalya, Konyaaltı, Turkey
Patients applied
Trial Officials
Mediha SERT GÖKÇEBEL, Researcher
Study Director
Akdeniz University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported